X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
female (10) 10
index medicus (10) 10
middle aged (10) 10
male (9) 9
adult (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
hematology (6) 6
oncology (6) 6
transplantation (6) 6
aged (5) 5
young adult (5) 5
chemotherapy (4) 4
hematopoietic stem cell transplantation - methods (4) 4
hematopoietic stem cells (4) 4
stem cells (4) 4
analysis (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
bone-marrow-transplantation (3) 3
combined modality therapy (3) 3
free survival (3) 3
hematopoietic stem cell transplantation - adverse effects (3) 3
hematopoietic stem cells - immunology (3) 3
medicine & public health (3) 3
mortality (3) 3
recurrence (3) 3
survival rate (3) 3
t cells (3) 3
transplantation conditioning - methods (3) 3
transplantation, homologous (3) 3
treatment outcome (3) 3
1st complete remission (2) 2
1st-line treatment (2) 2
adolescent (2) 2
age (2) 2
cancer (2) 2
care and treatment (2) 2
cisplatin (2) 2
clinical trials (2) 2
cytarabine - administration & dosage (2) 2
disease-free survival (2) 2
diseases (2) 2
genetic aspects (2) 2
genetics (2) 2
graft vs host disease - etiology (2) 2
graft vs host disease - prevention & control (2) 2
haploidentical hematopoietic cell transplantation (2) 2
haplotypes (2) 2
hematology, oncology and palliative medicine (2) 2
hematopoietic stem cells - cytology (2) 2
immunosuppressive agents - adverse effects (2) 2
incidence (2) 2
internal medicine (2) 2
kaplan-meier estimate (2) 2
leukemia (2) 2
lymphocyte depletion (2) 2
lymphomas (2) 2
multiple myeloma - drug therapy (2) 2
original article · originalarbeit (2) 2
patients (2) 2
prevention (2) 2
relapse (2) 2
retreatment (2) 2
stem cell transplantation (2) 2
stem-cell transplantation (2) 2
survival (2) 2
t-lymphocytes - immunology (2) 2
therapy (2) 2
transplantation conditioning (2) 2
tumors (2) 2
versus-host-disease (2) 2
1-phosphatidylinositol 3-kinase (1) 1
5-fluorouracil, continuous infusional (1) 1
5-ht (1) 1
5-ht3 antagonist (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[sdv.can] life sciences [q-bio]/cancer (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
abnormalities (1) 1
abridged index medicus (1) 1
activation (1) 1
acute gvhd (1) 1
acute myelogenous leukemia (1) 1
acute myeloid leukaemia (1) 1
acute myeloid-leukemia (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - pathology (1) 1
adjuvants, immunologic (1) 1
adult onset still’s disease (1) 1
advanced gastrointestinal cancer (1) 1
akt protein (1) 1
allogene transplantation (1) 1
allogeneic haematopoietic stem cell transplantation (1) 1
allogeneic transplantation (1) 1
allografts (1) 1
aml (1) 1
anakinra (1) 1
analysis of variance (1) 1
anemia, sickle cell - blood (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 11, pp. 1036 - 1047
Summary Background High-dose methotrexate is the standard of care for patients with newly diagnosed primary CNS lymphoma. The role of whole brain radiotherapy... 
Hematology, Oncology and Palliative Medicine | DEFERRED RADIOTHERAPY | 1ST-LINE TREATMENT | ONCOLOGY-GROUP | COMBINED-MODALITY THERAPY | ONCOLOGY | CONSOLIDATION RADIOTHERAPY | CELL TRANSPLANTATION | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | CHEMOTHERAPY | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Lymphoma - mortality | Antimetabolites, Antineoplastic - administration & dosage | Central Nervous System Neoplasms - radiotherapy | Lymphoma - drug therapy | Time Factors | Dose Fractionation | Female | Lymphoma - radiotherapy | Radiotherapy, Adjuvant | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Chi-Square Distribution | Cranial Irradiation - adverse effects | Cytarabine - administration & dosage | Disease-Free Survival | Methotrexate - adverse effects | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Methotrexate - administration & dosage | Aged | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Germany | Chemotherapy | Radiation | Product development | Lymphomas | Methotrexate | Radiotherapy | Biometry | Cancer
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 1487 - 1487
Abstract Introduction In acute leukemias, specific cytogenetic aberrations frequently correlate with myeloid or lymphoid phenotype of blasts and influence risk... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2017, Volume 176, Issue 3, pp. 431 - 439
Summary This study analysed the outcome of 267 patients with relapse/refractory acute myeloid leukaemia (AML) who received sequential chemotherapy including... 
sequential chemotherapy | reduced intensity conditioning | acute myeloid leukaemia | allogeneic haematopoietic stem cell transplantation | CYTOSINE-ARABINOSIDE | FREE SURVIVAL | BONE-MARROW-TRANSPLANTATION | 1ST COMPLETE REMISSION | MYELODYSPLASTIC SYNDROME | MATCHED UNRELATED DONORS | GRAFT-VERSUS-LEUKEMIA | HIGH-RISK | HLA-IDENTICAL SIBLINGS | HOST-DISEASE | HEMATOLOGY | Recurrence | Humans | Middle Aged | Male | Hematopoietic Stem Cell Transplantation - mortality | Leukemia, Myeloid, Acute - complications | Young Adult | Allografts | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Surveys and Questionnaires | Retrospective Studies | Transplantation Conditioning - methods | Graft vs Host Disease - etiology | Leukemia, Myeloid, Acute - therapy | Antibodies - therapeutic use | Survival Rate | Treatment Outcome | Combined Modality Therapy | Leukemia, Myeloid, Acute - mortality | Antibodies - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | T-Lymphocytes - immunology | Aged | Hematopoietic Stem Cell Transplantation - methods | Salvage Therapy - methods | Surveys | Viral antibodies | Chemotherapy | Relapse | Stem cells | Antibodies | Transplantation | T cells | Hematopoietic stem cells | Diseases | Cancer | Graft-versus-host reaction | Immunoglobulins | Transplants & implants | Leukemia | Stem cell transplantation | Transplants | Lymphocytes T | Multivariate analysis | Patients | Survival | Incidence | Cytarabine | Fludarabine | Donors | Conditioning
Journal Article
Molecular Therapy, ISSN 1525-0016, 05/2011, Volume 19, Issue 5, pp. 990 - 999
Journal Article
Annals of Hematology, ISSN 0939-5555, 9/2014, Volume 93, Issue 9, pp. 1579 - 1586
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2017, Volume 179, Issue 4, pp. 586 - 597
Journal Article
Annals of Hematology, ISSN 0939-5555, 10/2016, Volume 95, Issue 10, pp. 1627 - 1636
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 5/2017, Volume 96, Issue 5, pp. 817 - 827
Journal Article
Journal Article